The Development Of Novel Antibacterials Targeting Clostridium Difficile Infections [ 2013 - 2016 ]

Research Grant

Researchers: Prof Stephen Pyne (Principal investigator) ,  Prof Dena Lyras ,  Prof Paul Keller ,  Prof Thomas Riley

Brief description Clostridium difficile is a bacterium associated with infections in the gut which may result in mild to severe diarrhoea and inflammation of the colon. These infections are an increasing problem for hospitalised patients in the US, the EU and Australia. We have been very successful in the past at developing new drugs to treat external infections caused by resistant strains of bacteria, for example, golden Staph. We now aim to develop our drugs to treat C. difficile infections in the gut.

Funding Amount $AUD 750,546.69

Funding Scheme Project Grants

Notes Standard Project Grant